Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2015

Feb 18, 2015

34978_dirs_2015-02-18_c657eb16-c57e-4c9c-88e0-d611382a4503.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2015-02-17

Reporting Person: Steckel Ronald (VP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-17 Common Stock M 625 $3.856 Acquired 32589 Direct
2015-02-17 Common Stock S 625 $9.7936 Disposed 31964 Direct
2015-02-17 Common Stock M 1025 $3.99 Acquired 32989 Direct
2015-02-17 Common Stock S 1025 $9.7936 Disposed 31964 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-17 Stock Option Right to Buy $3.856 M 625 Disposed 2017-01-01 Common Stock (625) Direct
2015-02-17 Stock Option Right to Buy $3.99 M 1025 Disposed 2016-04-16 Common Stock (1025) Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Selling Plan adopted by the reporting person on 3/5/13.

F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.

F3: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.

F4: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.